📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial. (2023)

First Author: Alexander S

Attributed to: Clonal heterogeneity and therapy resistance in Burkitt lymphoma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2352-3026(23)00062-5

PubMed Identifier: 37094596

Publication URI: http://europepmc.org/abstract/MED/37094596

Type: Journal Article/Review

Volume: 10

Parent Publication: The Lancet. Haematology

Issue: 6

ISSN: 2352-3026